Jacobs Levy Equity Management, Inc Morphic Holding, Inc. Transaction History

Jacobs Levy Equity Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$45.13 - $64.99 $1.6 Million - $2.31 Million	-35,514 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$29.77 - $84.85 $375,221 - $1.07 Million	-12,604 Reduced 26.19%	35,514 $2.25 Million
Q4 2020 Feb 16, 2021	BUY	$25.66 - $34.55 $611,298 - $823,084	23,823 Added 98.06%	48,118 $1.61 Million
Q3 2020 Nov 16, 2020	BUY	$22.51 - $30.11 $141,205 - $188,880	6,273 Added 34.81%	24,295 $664,000
Q2 2020 Aug 17, 2020	BUY	$12.65 - $29.57 $227,978 - $532,910	18,022 New	18,022 $487,000

140

38.7M

4.2K

200K

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.